GYRE

Insider trade Sale by Luo Ying (Chief Executive Officer)

25d ago

News Gyre Therapeutics Completes Acquisition of Cullgen to Create U.S.- and China-based Fully Integrated Biopharmaceutical Company

29d ago

News Gyre Therapeutics GAAP EPS of -$0.02 misses by $0.09, revenue of $37.2M beats by $1.76M

82d ago

SEC filing GYRE Acquires Cullgen for $300M in All-Stock Deal, Gains TPD/DAC Platform

92d ago

News Philips jumps as Q4 net income rises and plans new dividend

112d ago

News Philips outlines 2026 sales growth of 3%–4.5% and margin expansion amid strong North America demand

112d ago

News Philips Proposes Extension of CEO’s Tenure After Guiding For Higher Profitability

112d ago

News Philips reports Q4 results

112d ago

News Philips Sees Mid-Term Margin, Sales Goals Around Current Levels

112d ago

News TopGum Signs Binding LOI to Acquire U.S. Operations and Expand into the Pharmaceutical Domain

132d ago

News Gyre Therapeutics to Present Results from Positive Phase 3 Clinical Trial Evaluating Hydronidone for the Treatment of Liver Fibrosis in Chronic Hepatitis B at AASLD—The Liver Meeting® 2025

153d ago

News Gyre Therapeutics Reports Third Quarter 2025 and Year-to-Date Financial Results and Provides Business Update

153d ago